On August 3, 2022 2seventy bio, Inc. (Nasdaq: TSVT) reported that members of the management team will participate in the following upcoming investor conferences (Press release, 2seventy bio, AUG 3, 2022, View Source [SID1234617331]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Wedbush PacGrow Healthcare Conference, "A View to a Kill(er Cell) – Part 1" panel on Wednesday, August 10, 2022 at 1:10 pm ET
42nd Annual Canaccord Genuity Growth Conference, fireside chat on Thursday, August 11, 2022 at 2:30 pm ET, the InterContinental Boston, Boston, MA
A live webcast will be available via the Investors and Media section of 2seventy bio’s website at View Source A replay will be archived on 2seventy bio’s site for 30 days following the event.